country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-165450

Copy Link Print Information

NNC-112

NNC-112 is a dopamine D1 receptor antagonist with a K_i of 0.18 nM for rat D1R and a K_i of 18 nM for 5-HT2. NNC-112 competitively inhibits [³H]SCH 23390 binding and blocks dopamine-stimulated adenylate cyclase. NNC-112 blocks D1 receptor-mediated rotational behavior in 6-OHDA-lesioned rats. NNC-112 can serve as a C11-labeled radioligand ([11C] NNC 112) for positron emission tomography imaging. NNC-112 can be used for research on schizophrenia and hypertension.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 125341-24-4
Formel: C₁₉H₁₈ClNO₂
Molecular Weight:327.81

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

NNC-112 Chemical Structure

CAS. Nr.: 125341-24-4

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

IC₅₀ & Target

^[2]

D₁ Receptor

0.18 nM (Ki)

5-HT_2A Receptor

18 nM (Ki)

Alle Dopamine Receptor Isoform-spezifische Produkte anzeigen :

Alle 5-HT Receptor Isoform-spezifische Produkte anzeigen :

In Vitro

NNC-112 (60 min) is a highly potent inhibitor of the binding of [³H]SCH 23390 to rat striatal dopamine D₁ receptors, with a K_I of 0.18 nM^[2].
NNC-112 (20 min) exhibits low affinity for rat striatal dopamine D₂ receptors, with a K_I of 898 nM^[2].
NNC-112 exhibits moderate affinity for 5-HT₂ receptors with a K_I of 18 nM^[2].
NNC-112 (15 min) is a potent competitive inhibitor of dopamine-stimulated adenylate cyclase in rat striatal tissue, with a K_I of 2.8 nM^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

NNC-112 (s.c.; 0.5 h before sacrifice) is a potent and selective inhibitor of D₁ receptor binding in mice, with an ED₅₀ of 0.015 mg/kg, and shows no activity at D₂ receptors^[2].
NNC-112 (s.c.; 0.5 h before the agonist) selectively antagonizes D₁ receptor-mediated rotational behavior in 6-OHDA (HY-B1081A)-lesioned rats with an ED₅₀ of 0.08 mg/kg, without affecting D₂-mediated rotation^[2].
Pretreatment with NNC-112 (2-2.5 mg/kg; i.v.) produces 77% blockade of [¹¹C]NNC 112 binding in the rat renal cortex, indicating that the PET signal is predominantly driven by specific D₁-like receptor binding^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Sprague-Dawley rats^[4]
Dosage:

2 mg/kg; 2.5 mg/kg
Administration:

i.v.; single pretreatment bolus
Result:

Reached an average of 0.083% injected dose per mL of tissue at 35 min in the left renal cortex, corresponding to a blocking percentage of 77%.

Related Protocols :

Research Protocol for Cardiovascular Diseases

Chemical Information

CAS. Nr. 125341-24-4
Molecular Weight 327.81
Formel C₁₉H₁₈ClNO₂
SMILES

CN1C[C@@H](C=2C(=CC(Cl)=C(O)C2)CC1)C3=C4C(=CC=C3)C=CO4
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Verma M. Evaluating a Positive Allosteric Modulator Radiotracer Candidate to Image the Dopamine D1 Receptor (Doctoral dissertation, Université d'Ottawa| University of Ottawa).

[2]. Andersen PH, et al. NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists. European journal of pharmacology. 1992 Aug 14;219(1):45-52. [Content Brief]

[3]. Sedvall GC, et al. Pharmacological manipulation of D1-dopamine receptor function in schizophrenia. Neuropsychopharmacology. 1999 Dec 1;21(6):S181-8.

[4]. Granda ML, et al. First D1-like receptor PET imaging of the rat and primate kidney: implications for human disease monitoring. American journal of physiology. Renal physiology. 2014 Jul 01;307(1):F116-21.

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen

Amount: USD 0.00

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

NNC-112

Alle Dopamine Receptor Isoform-spezifische Produkte anzeigen

Alle 5-HT Receptor Isoform-spezifische Produkte anzeigen